DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-9.11%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$377M
AUM Growth
+$377M
(-21%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
50.73%
Holding
91
New
7
Increased
20
Reduced
15
Closed
11
Top Buys
| 1 |
Cytokinetics
CYTK
|
$6.26M |
| 2 |
IDEAYA Biosciences
IDYA
|
$3.27M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$2.64M |
| 4 |
Alector
ALEC
|
$2.45M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$2.24M |
Top Sells
| 1 |
Theravance Biopharma
TBPH
|
$10.6M |
| 2 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$10.4M |
| 3 |
ProQR Therapeutics
PRQR
|
$6.16M |
| 4 |
LMNX
Luminex Corp
LMNX
|
$5.12M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$4.5M |
Sector Composition
| 1 | Healthcare | 91.17% |
